TG Therapeutics(CH:NKB2)
CH:NKB2
TG Therapeutics earnings date
TG Therapeutics (NKB2) Q2 2024 Earnings Report
0 Followers
CH:NKB2 Q2 2024 EPS Results
- Actual EPS
- CHF 0.03
- Consensus EPS
- -CHF 0.04
- Beat/Miss
- Beat by +CHF 0.07
- One Year Ago EPS
- -CHF 0.28
CH:NKB2 Q2 2024 Revenue Results
- Actual Revenue
- CHF 60.64M
- Expected Revenue
- CHF 54.42M
- Beat/Miss
- Beat by +CHF 6.23M
- YoY Revenue Growth
- +357.05%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- Before Open
- Conference Call
- Tuesday, August 6, 2024
CH:NKB2 Upcoming Earnings
TG Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CH:NKB2 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:NKB2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 0.43- | 0.12 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | 0.300.29 | 2.01 | -85.60% (-1.72) | |
| Aug 03, 2026 | 2026 (Q2) | 0.250.04 | 0.14 | -70.59% (-0.10) | |
| May 06, 2026 | 2026 (Q1) | 0.230.10 | 0.02 | 300.00% (+0.07) | |
| Feb 26, 2026 | 2025 (Q4) | 0.290.12 | 0.12 | -6.67% (-0.01) | |
| Nov 03, 2025 | 2025 (Q3) | 0.182.01 | 0.02 | 12050.00% (+1.99) | |
| Aug 04, 2025 | 2025 (Q2) | 0.170.14 | 0.03 | 325.00% (+0.11) | |
| May 05, 2025 | 2025 (Q1) | 0.140.02 | -0.06 | 142.86% (+0.08) | |
| Mar 03, 2025 | 2024 (Q4) | 0.130.12 | -0.07 | 266.67% (+0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 0.020.02 | 0.6 | -97.26% (-0.59) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

